FDA Drug Application (021711) for ABLAVAR by LANTHEUS MEDCL

Back to FDA Applications sponsored by LANTHEUS MEDCL

Application Number021711
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage2440MG/10ML (244MG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABLAVAR
Active IngredientGADOFOSVESET TRISODIUM



Back to FDA Applications sponsored by LANTHEUS MEDCL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.